🔎 Trials Near Me

Akèy › Limfom Difize Gwo Selil B › Kalifòni › Baldwin Park

Etid klinik pou Limfom Difize Gwo Selil B nan Baldwin Park, CA

19 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Baldwin Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Ap rekriteFaz 2
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06500273

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Ap rekriteFaz 1
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07195916

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Ap rekriteFaz 1
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT05272384

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Ap rekriteFaz 2
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07365306

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Ap rekriteFaz 1/2
  • City of Hope, Duarte · 4 mi lwen
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05077527

Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Ap rekriteFaz 2
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05672251

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Ap rekriteFaz 1
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT06015880

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT05131022

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT06859008

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Ap rekriteFaz 1/2
  • City of Hope, Duarte · 4 mi lwen
Laj 12 a 95 · Tout sèks · Mizajou Apr 15, 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • City of Hope, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT04830137

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Ap rekriteFaz 1 bonè
  • City of Hope Medical Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT05800405

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Ap rekriteFaz 2
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 20, 2025 · NCT05890352

Etid Limfom Difize Gwo Selil B nan lòt vil

Lòt etid nan Baldwin Park

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.